¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"È¿"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
effective quantum number
À¯È¿¾çÀÚ¼ö
effective renal blood flow
À¯È¿ÄáÆÏÇ÷·ù·®, À¯È¿½ÅÀåÇ÷·ù·®
effective renal plasma flow
À¯È¿ÄáÆÏÇ÷ÀåÀ¯·®, À¯È¿½ÅÀåÇ÷ÀåÀ¯·®
effective temperature index
À¯È¿¿ÂµµÁö¼ö
effectiveness
1. À¯È¿µµ 2. È¿À² 3. À¯¿ëµµ
effector
1. È¿°ú±â 2. ÀÛµ¿Ã¼ 3. È¿°úÀÎÀÚ 4. ÀÛ¿ëÀÎÀÚ
efficiency
1. È¿À², È¿À²¼º 2. ´É·ü
efficient coitus
À¯È¿¼º±³
endoenzyme
³»È¿¼Ò
endonuclease
ÇÙ¼ÓÇÙ»êºÐÇØÈ¿¼Ò, ¿£µµ´ºÅ¬·¹¾ÆÁ¦
endopeptidase
ÆéƼµå³»ºÎºÐÇØÈ¿¼Ò, ¿£µµÆéƼ´Ù¾ÆÁ¦
endpoint PCR
³¡Á¡ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
epimerase
ÀÔüÀ̼ºÃ¼È¿¼Ò
ectoenzyme
¿ÜÈ¿¼Ò
esterase
¿¡½ºÅ׸£ºÐÇØÈ¿¼Ò
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
endopeptidase
ÆéƼµå³»ºÎºÐÇØÈ¿¼Ò, ¿£µµÆéƼ´Ù¾ÆÁ¦
esterase
¿¡½ºÅ׸£ºÐÇØÈ¿¼Ò
exoenzyme
¼¼Æ÷¿ÜÈ¿¼Ò, ±Õü¹ÛÈ¿¼Ò
exonuclease
Çٻ긻´ÜºÐÇØÈ¿¼Ò, ¿¢¼Ò´ºÅ¬·¹¾ÆÁ¦
exopeptidase
ÆéƼµå¸»´ÜºÐÇØÈ¿¼Ò, ¿¢¼ÒÆéƼ´Ù¾ÆÁ¦
effective mass
À¯È¿Áú·®
effective value
À¯È¿°ª
effective alveolar ventilation
À¯È¿ÆóÆ÷ȯ±â, À¯È¿ÆóÆ÷ȯ±â·®
effective blood volume
À¯È¿Ç÷¾×·®
effective circulating volume
À¯È¿¼øÈ¯¿ëÀû
effective dose equivalent
À¯È¿¼±·®ÇØ´ç·®
effective filtration pressure
À¯È¿¿©°ú¾Ð
effective membrane resistance
À¯È¿¸·ÀúÇ×
effective perceived noise level
½ÇÈ¿°¨¼ö¼ÒÀ½¼öÁØ, ½ÇÁ¦°¨°¢¼ÒÀ½
effective quantum number
À¯È¿¾çÀÚ¼ö
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
angiotensin converting enzyme inhibitor
¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦¹°Áú<¾à>.
angiotensin-converting enzyme
¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò
anhydrase
¾ÈÈ÷µå¶óÁ¦, Å»¼öÈ¿¼Ò
anhydrase
¾ÈÈ÷µå¶óÁ¦<Å»¼öÈ¿¼Ò>.
antagonistic effect
±æÇ×È¿°ú
antibody to histidyl tRNa synthetase
È÷½ºÆ¼µô tRNa ÇÕ¼ºÈ¿¼Ò¿¡ ´ëÇÑ Ç×ü
anticoagulant effect
Ç×ÀÀ°íÈ¿°ú.
antienzyme dentifrice
Ç×È¿¼Ò¼º Ä¡Á¦(ù÷ý£áÈàõöÍð¥).
antioxidant effect
Ç×»êÈÈ¿°ú(¡üùÍý).
antioxidase
Ç×»êÈÈ¿¼Ò(ù÷ß«ûùý£áÈ).
antiprotease
Ç״ܹéÈ¿¼Ò(ù÷Ó±ÛÜý£áÈ)
antitoxemic effect
Ç×µ¶Ç÷ÁõÈ¿°ú.
antitussive effect
ÁøÇØÈ¿°ú(òåú¦üùÍý).
antiyeast substance
Ç×È¿¸ð¹°Áú.
apoenzyme
¾ÆÆ÷È¿¼Ò.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
combined effect
º´¿ëÈ¿°ú(ܱéÄüùÍý).
combined effect
º´¿ëÈ¿°ú
combustion efficiency
¿¬¼ÒÈ¿À²(¡üùëÒ).
committed effective dose
¿¹Å¹À¯È¿¼±·®
committed effective dose equivalent
¿¹Å¹À¯È¿¼±·®´ç·®
compton effect
ÄÞÅæÈ¿°ú
concentration effect
³óÃàÈ¿°ú, ³óµµÈ¿°ú(¡üùÍý).
concentration effect
³óÃàÈ¿°ú, ³óµµÈ¿°ú(¡üùÍý).
congenital deficiency of glucuronyl transfe ra se
¼±Ãµ¼º ±Û·çÄí·Ð»ê Àü À§È¿¼Ò°áÇÌÁõ(¡ï®êÈý£áÈÌÀù¹ñø).
constitutive enzyme
±¸¼ºÈ¿¼Ò(ϰà÷ý£áÈ).
constitutive enzyme
±¸¼ºÀûÈ¿¼Ò (±âº»)
convertase
Àüȯȿ¼Ò(ï®üµý£áÈ).
converting enzyme inhibitor
Àüȯȿ¼Ò¾ïÁ¦Á¦.
cophosphorylase
ÀλêÈÈ¿¼Ò º¸È¿¼Ò(ìÝß«ûùý£áÈÜÍý£áÈ), ÄÚÆ÷½ºÆ÷¸±¶óÁ¦.
cost-effectiveness analysis
ºñ¿ë-È¿°úºÐ¼®.
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
10
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½